Medco Celesio B.V.

This site contains information on Medco Celesio B.V., a joint venture of
Medco Health Solutions, Inc. and Celesio AG.

Celesio and Medco, two of the world’s leading pharmacy-driven healthcare companies, announced a joint venture on June 21, 2010. The joint venture was approved by the German Federal Competition Authority on August 2, 2010. The long term-goals of the joint venture are to improve patient health and help relieve the crushing financial burden on healthcare payors across Europe.

Headquartered in Amsterdam, the 50/50 joint venture, Medco Celesio B.V., combines Medco’s and Celesio’s strengths in pharmacy-driven clinical care. Medco Celesio B.V. will focus on patients with chronic or complex conditions, such as diabetes, asthma, high-cholesterol and heart disease. It will concentrate on innovative, integrated clinical services designed to improve patient adherence, integrate care across multiple providers, enhance safety and deliver greater value across the healthcare system.

» Click here to view the webcast of the press conference in Berlin in English*

» Click here to view the webcast of the press conference in Berlin in German*

» Click here to view the webcast of the press conference in Berlin in French*

*By selecting this link, you will be leaving the corporate site and linking to another website,
which may be governed by a separate and different Terms of Use and Privacy Policy.